Patents by Inventor Justine M. Kent

Justine M. Kent has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods Of Treating Depression Using Orexin-2 Receptor Antagonists
    Publication number: 20220105094
    Abstract: The present disclosure is directed to, inter alia, methods of treating a subject suffering from or diagnosed with depression, comprising administering to a subject in need of such treatment an effective amount of a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein R1 to R4 are described herein and wherein the compound is administered prior to sleep.
    Type: Application
    Filed: December 15, 2021
    Publication date: April 7, 2022
    Inventors: Peter De Boer, Justine M. Kent, Wayne C. Drevets
  • Methods of treating depression using orexin-2 receptor antagonists
    Patent number: 11241432
    Abstract: The present disclosure is directed to, inter alia, methods of treating a subject suffering from or diagnosed with depression, comprising administering to a subject in need of such treatment an effective amount of a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein R1 to R4 are described herein and wherein the compound is administered prior to sleep.
    Type: Grant
    Filed: November 9, 2020
    Date of Patent: February 8, 2022
    Assignee: Janssen Pharmaceutica NV
    Inventors: Peter De Boer, Justine M. Kent, Wayne C. Drevets
  • Methods Of Treating Depression Using Orexin-2 Receptor Antagonists
    Publication number: 20210052588
    Abstract: The present disclosure is directed to, inter alia, methods of treating a subject suffering from or diagnosed with depression, comprising administering to a subject in need of such treatment an effective amount of a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein R1 to R4 are described herein and wherein the compound is administered prior to sleep.
    Type: Application
    Filed: November 9, 2020
    Publication date: February 25, 2021
    Inventors: Peter De Boer, Justine M. Kent, Wayne C. Drevets
  • Methods of treating depression using orexin-2 receptor antagonists
    Patent number: 10828302
    Abstract: The present disclosure is directed to, inter alia, methods of treating a subject suffering from or diagnosed with depression, comprising administering to a subject in need of such treatment an effective amount of a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein R1 to R4 are described herein and wherein the compound is administered prior to sleep.
    Type: Grant
    Filed: March 9, 2017
    Date of Patent: November 10, 2020
    Assignee: Janssen Pharmaceutica NV
    Inventors: Peter De Boer, Justine M. Kent, Wayne C. Drevets
  • Methods Of Treating Depression Using Orexin-2 Receptor Antagonists
    Publication number: 20170258790
    Abstract: The present disclosure is directed to, inter alia, methods of treating a subject suffering from or diagnosed with depression, comprising administering to a subject in need of such treatment an effective amount of a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein R1 to R4 are described herein and wherein the compound is administered prior to sleep.
    Type: Application
    Filed: March 9, 2017
    Publication date: September 14, 2017
    Inventors: Peter De Boer, Justine M. Kent, Wayne C. Drevets